International Atomic Energy Agency Wagramer Strasse 5, P.O.Box 100, A-1400 Vienna, Austria e-mail:services@iaeand.iaea.or.at

Established Radioisotopes Therapeutic radioisotopes that have established clinical uses

Radionuclide	T 1/2	Emax in MeV	Production route	R/A/D *
^32P	14.3 d	1.7 b^-	^31P(n, g)	R
			^32S(n, p)	R,A
^89Sr	50.5 d	1.5 b^-	^89Y(n, p)	R,A
			^88Sr(n, g)	R
^90Y	2.7 d	2.3 b^-	^90Zr(n, p)	R,A
			^89Y(n, g)	R
			^235U(n, f) FP ^90Sr ® ^90Y generator	R
^103Pd	17.0 d	Auger electrons, x-rays	^102Pd(n, g)	R
			^103Rh(p, n)	A
			^103Rh(d, 2n)	A
			^104Pd(g,n)	A
^125I	60.0 d	Auger electrons	^124Xe(n,g)^125Xe ® ^125I generator	R
^131I	8.0 d	0.6 b^-	^130Te(n,g) ® ^131Te ®^131I	R
			^235U(n, f) FP	R
^137Cs	30.97 y	0.5 b^-	^235U(n, f) FP	R
^153Sm	1.9 d	0.8 b^-	^152Sm(n,g)	R
^186Re	17.0 h	1.1 b^-	^185Re(n,g)	R
			^186W(p, n),^186W(d, 2n)	A
^188Re	17.0 h	2.0 b^-	^186W(n,g) ® ^187W(n, g)^188W ® ^188Re generator	R
			^187Re(n,g)	R
^192Ir	73.8 d	0.7 b^-	^191Ir(n,g)	R
			^192Os(p, n)^192Ir	A
			^192Os(d, 2n)^192Ir	A